Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

被引：0
作者：
Boncompagni, Riccardo [1 ]
Staderini, Michela [2 ]
Nozzoli, Chiara [1 ]
Antonioli, Elisabetta [2 ]
Caporale, Roberto [3 ]
Peruzzi, Benedetta [3 ]
Cutini, Ilaria [1 ]
Gozzini, Antonella [1 ]
Serena, Mariotti [1 ]
Guidi, Stefano [1 ]
Jance, Blerina [3 ]
Accogli, Barbara [2 ]
Francesco, Annunziato [3 ]
Bosi, Alberto [2 ]
Saccardi, Riccardo [1 ]
机构：
[1] AOU Careggi, Cell Therapy & Transfus Med Unit, Florence, Italy
[2] AOU Careggi, Hematol Unit, Florence, Italy
[3] AOU Careggi, Diagnost Ctr Cytometry & Immunotherapy, Florence, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
autologous stem cell transplant; Minimal residual disease; Progression-free survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-203
引用
收藏
页码：E172 / E172
页数：1
相关论文
共 50 条
  • [21] Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status
    J Esteve
    N Villamor
    D Colomer
    F Cervantes
    E Campo
    E Carreras
    E Montserrat
    Leukemia, 2001, 15 : 445 - 451
  • [22] Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy
    Mo, Clifton C.
    Hartley-Brown, Monique A.
    Midha, Shonali
    Richardson, Paul G.
    CANCERS, 2023, 15 (24)
  • [23] Stem Cell Transplantation in Multiple Myeloma
    Offidani, Massimo
    Gentili, Silvia
    Gay, Francesca
    Aghemo, Elena
    Maracci, Laura
    Corvatta, Laura
    Palumbo, Antonio
    CURRENT CANCER DRUG TARGETS, 2017, 17 (09) : 769 - 781
  • [24] A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-Cell Lymphoma: Impact of Autologous Stem Cell Transplant (ASCT)
    Foley, Nicole
    Russler-Germain, David
    Watkins, Marcus
    Jacobsen, Eric
    Moskowitz, Alison
    Cashen, Amanda
    Fehniger, Todd
    Kahl, Brad
    Bartlett, Nancy
    Ghobadi, Armin
    Reagan, Beth
    Fischer, Anne
    Wan, Fei
    Jacobsen, Austin
    Elias, Karina
    Holman, Matt
    Hill, Natalie
    Gordon, Skylar
    Huang, Ying
    Horwitz, Steven
    Mehta-Shah, Neha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S464 - S464
  • [25] Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
    de Tute, Ruth M.
    Rawstron, Andy C.
    Gregory, Walter M.
    Child, J. Anthony
    Davies, Faith E.
    Bell, Sue E.
    Cook, Gordon
    Szubert, Alexander J.
    Drayson, Mark T.
    Jackson, Graham H.
    Morgan, Gareth J.
    Owen, Roger G.
    HAEMATOLOGICA, 2016, 101 (02) : E69 - E71
  • [26] Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival
    E González-Barca
    A Fernández de Sevilla
    A Domingo-Claros
    V Romagosa
    GA Martín-Henao
    S De Sanjose
    M Carmona
    J Petit
    J García
    A Grañena
    Bone Marrow Transplantation, 2000, 26 : 1051 - 1056
  • [27] Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
    Cowan, Andrew J.
    Stevenson, Philip A.
    Cassaday, Ryan D.
    Graf, Solomon A.
    Fromm, Jonathan R.
    Wu, David
    Holmberg, Leona A.
    Till, Brian G.
    Chauncey, Thomas R.
    Smith, Stephen D.
    Philip, Mary
    Orozco, Johnnie J.
    Shustov, Andrei R.
    Green, Damian J.
    Libby, Edward N., III
    Bensinger, William I.
    Shadman, Mazyar
    Maloney, David G.
    Press, Oliver W.
    Gopal, Ajay K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 380 - 385
  • [28] Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma
    Rossi, Giovanni
    Falcone, Antonietta Pia
    Minervini, Maria Marta
    De Cillis, Giovanni Pio
    De Waure, Chiara
    Sisti, Leuconoe Grazia
    Giambra, Vincenzo
    Valente, Daniela
    Chiello, Vincenzo
    Scalzulli, Potito Rosario
    Carella, Angelo Michele
    Cascavilla, Nicola
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (03) : 195 - 200
  • [29] Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission:: toxicity, follow-up of minimal residual disease and survival
    González-Barca, E
    de Sevilla, AF
    Domingo-Claros, A
    Romagosa, V
    Martín-Henao, GA
    De Sanjose, S
    Carmona, M
    Petit, J
    García, J
    Grañena, A
    BONE MARROW TRANSPLANTATION, 2000, 26 (10) : 1051 - 1056
  • [30] Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia
    Appelbaum, Frederick R.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (03) : 279 - 284
12345